Fastly Inc (FSLY) Stock Price Today
Aura AI Summary
Key Stats
- $4.06BMarket Cap
- 3,043,964Volume
- TechnologySector
- $33.5052W High
- $7.8652W Low
- 26 DaysTypical Hold Time
- $4.12BEnterprise Value
- -Div Yield
- 60% Sell | 40% BuyTrading Activity
Track Fastly Inc (FSLY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Fastly Inc has traded between a low of $7.86 and a high of $33.5, highlighting its annual price range. Buy and sell Fastly Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Fastly Inc
Fastly operates a content delivery network, which is necessary for entities to provide faster and more reliable online content. Fastly's strategy differs from traditional CDNs, which focused on locating servers in as many locations as possible to store copies of files that consumers most use. Fastly has far fewer sites than traditional CDNs, but it houses servers in the most network-dense data centers. Instead of simply storing static content, it allows its customers to program on its platform, enabling edge computing and better service of the more dynamic content that was traditionally not well served by CDNs. Fastly gears its service to the largest, most sophisticated enterprises rather than small companies and generated about two thirds of its revenue in the United States in 2020.
Most Recent News
MMR vaccines now available at 530+ CVS locations in New York amid measles outbreak
In response to a measles outbreak and statewide emergency in New York, CVS Health is offering measles-mumps-rubella (MMR) vaccinations at over 530 CVS Pharmacy locations and MinuteClinic sites across the state. The MMR vaccine is crucial to prevent t...
Best Eli Lilly stock buys were during crises, not at hype peaks of Mounjaro and Zepbound drug approvals.
Eli Lilly's most profitable stock entry points were during less hyped events like the 2008 ImClone acquisition and the 2014 Trulicity approval, yielding returns over 2,000%. In contrast, buying at the peaks of hype around blockbuster drugs Mounjaro a...
JP Morgan expects ASML to signal strong 2027 outlook with robust semiconductor demand in Q3 results.
JP Morgan analyst Sandeep Deshpande anticipates that ASML, the Dutch semiconductor equipment maker, will report a stronger-than-expected outlook for 2027 in its upcoming third-quarter results. The bank highlights robust demand for ASML's extreme ultr...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.